Dr. Sheikh Raza Shahzad, MBBS, MD

Dr. Shahzad practices at Renal Center of Keyser in Pompano Beach, Florida.

Dr. Shahzad's NPI, 1124512629, was assigned on June 18, 2018. Dr. Shahzad holds West Virginia license 31836.

Dr. Shahzad's primary practice is Renal Center of Keyser, at 3890 Park Central N Blvd, Pompano Beach, FL 33064 in Broward County. The practice phone is (304) 788-5057.

Dr. Shahzad's primary practice is Renal Center of Keyser in Pompano Beach, Florida. Dr. Shahzad is also affiliated with J.W. Ruby Memorial Hospital. The medical group on file is University Health Associates. Dmand AI also links Dr. Shahzad to 4 more hospitals, 1 dialysis center and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shahzad practices, 7 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Shahzad's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Shahzad is licensed in West Virginia.

CMS data shows 439 Medicare services from Dr. Shahzad across 7 procedure codes in 2024, for 167 Medicare patients. Medicare paid $66,918 for them.

CMS counts 167 Medicare patients who saw Dr. Shahzad in 2024. The largest group is 75 to 84, with 61 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 31% are also on Medicaid. Their average risk score is 5.00, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Shahzad's median patient age at 70, with 42% women.

In 2024, Dr. Shahzad wrote 296 Medicare Part D claims for 73 patients. 86% of them were for generic drugs. CMS names the drug for 153 of them, across 8 drugs with 11 or more claims each, at $3,616 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Shahzad for performance year 2024, reported through an alternative payment model (APM). Dr. Shahzad accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Shahzad as offering telehealth.

Dmand AI links 3 papers to Dr. Shahzad, published from 2019 to 2024. Dr. Shahzad has published most often in BMJ Case Rep. Dr. Shahzad's most frequent co-authors are Mustafa Erdem Arslan, MD, Glenn Matthew Chertow, MD and Calyani Ganesan, MD.

CMS Open Payments shows 4 general payments to Dr. Shahzad from 3 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 100% of the total. Mallinckrodt Hospital Products Inc. paid the most, $185.